Cargando…
Neural activity changes in first-episode, drug-naïve patients with major depressive disorder after transcutaneous auricular vagus nerve stimulation treatment: A resting-state fMRI study
INTRODUCTION: Major depressive disorder (MDD) is a disease with prominent individual, medical, and economic impacts. Drug therapy and other treatment methods (such as Electroconvulsive therapy) may induce treatment-resistance and have associated side effects including loss of memory, decrease of rea...
Autores principales: | Yi, Sijie, Wang, Zhi, Yang, Wenhan, Huang, Chuxin, Liu, Ping, Chen, Yanjing, Zhang, Huiting, Zhao, Guangju, Li, Weihui, Fang, Jiliang, Liu, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597483/ https://www.ncbi.nlm.nih.gov/pubmed/36312012 http://dx.doi.org/10.3389/fnins.2022.1018387 |
Ejemplares similares
-
Treating Depression with Transcutaneous Auricular Vagus Nerve Stimulation: State of the Art and Future Perspectives
por: Kong, Jian, et al.
Publicado: (2018) -
Transcutaneous auricular vagus nerve stimulation at 1 Hz modulates locus coeruleus activity and resting state functional connectivity in patients with migraine: An fMRI study
por: Zhang, Yue, et al.
Publicado: (2019) -
The effect of transcutaneous auricular vagus nerve stimulation on HRV in healthy young people
por: Geng, Duyan, et al.
Publicado: (2022) -
Brain–Heart Interaction During Transcutaneous Auricular Vagus Nerve Stimulation
por: Machetanz, Kathrin, et al.
Publicado: (2021) -
Transcutaneous auricular vagus nerve stimulation augments postprandial inhibition of ghrelin
por: Kozorosky, Erica M., et al.
Publicado: (2022)